Pharmaceutical companies in the United States by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
TG Therapeutics leads the 44 pharmaceutical companies in the United States ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- TG Therapeutics19.0%
- Median
- 7.16%
- Combined market value
- CZK 83.16T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | TG TherapeuticsTGTX · Health Care | 19.0% | CZK 218.3B | CZK 1,444.24 | 1.88% down | 103% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | CZK 180.3B | CZK 2,599.98 | 1.88% down | 15% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | CZK 106.3B | CZK 1,888.32 | 1.01% up | 105% up | ||
| 4 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | CZK 180.2B | CZK 2,760.70 | 2.47% down | 45% up | ||
| 5 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | CZK 193.4B | CZK 6,920.67 | 1.87% up | 83% up | ||
| 6 | CytokineticsCYTK · Health Care | 12.9% | CZK 159.6B | CZK 1,145.50 | 0.27% up | 21% down | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | CZK 100.9B | CZK 605.92 | 0.62% down | 64% down | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | CZK 127.8B | CZK 6,387.31 | 3.94% down | 44% up | ||
| 9 | Spyre TherapeuticsSYRE · Health Care | 12.2% | CZK 206.4B | CZK 2,173.25 | 3.77% down | 302% up | ||
| 10 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | CZK 100.3B | CZK 916.45 | 0.48% down | 82% up | ||
| 11 | BridgeBio PharmaBBIO · Health Care | 10.7% | CZK 339B | CZK 1,740.29 | 0.22% up | 15% up | ||
| 12 | ErascaERAS · Health Care | 10.6% | CZK 111.1B | CZK 316.54 | 3.34% up | 387% up | ||
| 13 | Cogent BiosciencesCOGT · Health Care | 10.0% | CZK 107.4B | CZK 617.50 | 0.25% down | 25% down | ||
| 14 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | CZK 138.8B | CZK 2,126.06 | 3.27% up | 35% up | ||
| 15 | Travere TherapeuticsTVTX · Health Care | 9.96% | CZK 103.2B | CZK 1,075.16 | 3.86% down | 39% up | ||
| 16 | Oruka TherapeuticsORKA · Health Care | 9.53% | CZK 147.3B | CZK 2,171.92 | 1.91% up | 233% up | ||
| 17 | PTC TherapeuticsPTCT · Health Care | 9.31% | CZK 108.5B | CZK 1,298.32 | 3.16% down | 26% down | ||
| 18 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | CZK 205.2B | CZK 8,831.47 | 0.34% down | 28% down | ||
| 19 | Corcept TherapeuticsCORT · Health Care | 8.34% | CZK 158.3B | CZK 1,446.46 | 4.15% down | 16% down | ||
| 20 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | CZK 137.4B | CZK 971.65 | 1.25% up | 8% up | ||
| 21 | VeradermicsMANE · Health Care | 8.03% | CZK 116.8B | CZK 2,768.93 | 0.38% down | 230% up | ||
| 22 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | CZK 264.8B | CZK 1,367.22 | 0.02% down | 12% up | ||
| 23 | Definium TherapeuticsDFTX · Health Care | 7.02% | CZK 89.8B | CZK 656.23 | 1.24% up | 176% up | ||
| 24 | Elanco Animal HealthELAN · Health Care | 6.59% | CZK 292.5B | CZK 585.22 | 1.54% down | 18% up | ||
| 25 | InsmedINSM · Health Care | 6.42% | CZK 705.5B | CZK 3,215.69 | 20.58% up | 27% down | ||
| 26 | Axsome TherapeuticsAXSM · Health Care | 6.20% | CZK 158.9B | CZK 3,020.25 | 1.25% up | 9% down | ||
| 27 | Legend BiotechLEGN · Health Care | 6.13% | CZK 69.5B | CZK 358.39 | 0.92% down | 43% down | ||
| 28 | Summit TherapeuticsSMMT · Health Care | 5.28% | CZK 188.2B | CZK 235.29 | 0.67% up | 35% down | ||
| 29 | United TherapeuticsUTHR · Health Care | 4.31% | CZK 530B | CZK 12,445.62 | 3.16% down | 18% up | ||
| 30 | ZoetisZTS · Health Care | 4.12% | CZK 730.7B | CZK 1,798.39 | 5.59% down | 34% down | ||
| 31 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | CZK 440.7B | CZK 3,290.49 | 1.06% down | 66% down | ||
| 32 | Belite BioBLTE · Health Care | 3.40% | CZK 136.5B | CZK 3,361.72 | 3.33% down | 25% up | ||
| 33 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | CZK 165.9B | CZK 476.14 | 2.24% down | 79% up | ||
| 34 | ViatrisVTRS · Health Care | 3.07% | CZK 507.3B | CZK 442.53 | 1.97% down | 90% up | ||
| 35 | PfizerPFE · Health Care | 2.36% | CZK 3.49T | CZK 613.04 | 1.85% down | 10% up | ||
| 36 | Bristol-Myers SquibbBMY · Health Care | 2.29% | CZK 2.65T | CZK 1,298.65 | 2.05% down | 26% up | ||
| 37 | Royalty PharmaRPRX · Health Care | 2.27% | CZK 866.8B | CZK 1,507.45 | 1.38% down | 74% up | ||
| 38 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | CZK 2.13T | CZK 20,553.64 | 2.35% down | 22% up | ||
| 39 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | CZK 2.94T | CZK 11,589.94 | 2.94% down | 22% up | ||
| 40 | Abbott LaboratoriesABT · Health Care | 1.10% | CZK 4T | CZK 2,312.16 | 0.58% down | 19% down | ||
| 41 | Merck & CoMRK · Health Care | 1.08% | CZK 7.29T | CZK 2,956.36 | 3.61% down | 36% up | ||
| 42 | AbbVieABBV · Health Care | 0.89% | CZK 11.16T | CZK 6,311.63 | 0.86% down | 20% up | ||
| 43 | Eli LillyLLY · Health Care | 0.81% | CZK 26.79T | CZK 30,076.07 | 2.29% down | 28% up | ||
| 44 | Johnson & JohnsonJNJ · Health Care | 0.71% | CZK 14.32T | CZK 5,946.56 | 2.04% down | 31% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2601 CZK).
Questions and answers
Which pharmaceutical companies in the United States rank first by short interest?
TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 44 pharmaceutical companies in the United States ranked by short interest as of the 30 Oct 2026 settlement date.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by short interest.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by short interest have a combined market value of CZK 83.16T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceutical companies in the United States by short interest”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.